The 21st Century Cures Act, passed by the Senate yesterday with overwhelming bipartisan support, is an important victory for biotechnology and medical innovation that will help expedite the development of the next generation medicines, expediate drug approval process, while helping to lower other healthcare costs. The bill provides for $4.8 billion in new funding for the National Institutes of Health; of that, $1.8 billion is reserved for the “cancer moonshot” launched by Vice President Biden to accelerate research in that field. Another $1.6 billion is earmarked for brain diseases including Alzheimer’s. Also included are $500 million in new funding for the Food and Drug Administration and $1 billion in grants to help states deal with opioid abuse, Washington Post reports. Read full story
Related Posts
UMaine professor McGill receives top German research award
ORONO — University of Maine ecology professor Brian McGill was awarded the Humboldt Research Award, one of the most prestigious scientific...
Four Maine workforce programs could get $6.5M in fed funding
Four workforce training programs in Maine could receive nearly $6.5 million in federal funding through the markup of the fiscal year 2024 financial...
Music as medicine: FDA approves stroke damage therapy from Portland startup
Doctors may soon start writing an unconventional prescription to help stroke survivors regain their ability to walk: music. MedRhythms, a Portland...